The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Cervical Cancer Research

Uterine Cervical Neoplasms Clinical Trial

Official title:

The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Stage Cervical Cancer

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02018003
• Other study ID #: PUCRP201309
• Status: Not yet recruiting
• Phase: N/A
• First received: December 17, 2013
• Last updated: December 20, 2013
• Start date: January 2014
• Est. completion date: December 2016

Study information

• Verified date: November 2013
• Source: Peking University
• Contact: Gao Weijiao
• Phone: 86-10-88196102
• Email: gaoweijiao[@]126.com
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to assess the women's quality of life, who accepted chemotherapy,radiotherapy, concurrent radiochemotherapy or who didn't accept therapy, after operation.

Description:

The study projects to follow up 180-200 early stage cervical cancer patients after operation and assess the women's quality of life by the scales: ECOG, Functional Assessment of Cancer Therapy, EuroQol-5 Dimensions, and Kupperman index.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 180
• Est. completion date: December 2016
• Est. primary completion date: October 2016
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• ? 18 years, cervical cancer verified by pathology,

• IIA stage, accepted the operation ( Piver III and pelvic lymph node dissection) as initial therapy, obtained the patient's agreement

Exclusion Criteria:

• the patient had accepted chemotherapy or radiotherapy before operation

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Uterine Cervical Neoplasms

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Peking University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life for the women with early stage cervical cancer who underwent operation		up to 12 months after operation	Yes